XBiotech Cash Flow Statement (2014-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Jun2026
Operating Activities
Net Income (Quarter)	-5.12M	-3.26M	-5.06M	-5.39M	-11.64M	-12.66M	-3.20M	-3.89M	-8.74M	-7.36M	-4.69M	-10.00M	-13.01M	-5.01M	-10.51M	-10.88M	-1.76M	-6.01M	-26.89M	-6.73M
Depreciation and Depletion (Quarter)	0.64M	0.69M	0.70M	0.71M	0.73M	0.73M	0.43M	0.44M	0.43M	0.43M	0.39M	0.43M	0.43M	0.44M	0.44M	0.44M	0.44M	0.43M	0.38M
Share-based Compensation (Quarter)	0.23M	1.13M	4.89M	1.45M	1.45M	1.13M	1.04M	0.70M	0.91M	0.95M	-2.57M	0.06M	0.38M	0.36M	0.63M	3.33M	98.00M	150.00M	0.16M	0.17M
Deferred Taxes (Quarter)
Change in Interest Receivables (Quarter)							1.22M	1.16M	0.85M	-2.34M	-0.02M	0.01M		-0.14M	-0.03M	-0.22M		-0.03M	-0.09M
Cash from Operations (Quarter)	72.80M	-3.40M	-1.76M	-5.12M	-5.39M	-1.15M	-3.16M	-4.81M	-9.00M	-1.49M	-3.43M	-7.20M	-11.38M	-5.84M	-6.54M	-6.72M	-5.99M	-4.26M	-22.95M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)	0.64M	0.69M	0.70M	0.71M	0.73M	0.73M	0.43M	0.44M	0.43M	0.43M	0.39M	0.43M	0.43M	0.44M	0.44M	0.44M	0.44M	0.43M	0.38M
Change in Working Capital
Change in Receivables (Quarter)	-1.66M	0.02M	-0.04M	0.50M	-0.50M	1.53M	-1.53M
Change in Account Payables (Quarter)	0.38M	-0.65M	1.17M	-0.81M	1.03M	-0.96M	1.10M	-1.06M	0.44M	-0.32M	1.03M	0.01M	-0.82M	-0.20M	0.65M	-1.12M	0.33M	-0.39M	0.49M
Change in Accured Expenses (Quarter)	0.34M	-0.04M	-0.27M	0.19M	4.02M	-3.60M	-0.39M	0.60M	0.43M	1.03M	-0.17M	0.69M	1.15M	-0.86M	-1.86M	1.67M	-1.89M	0.01M	3.90M
Change in Taxes (Quarter)	0.85M	0.49M	-1.12M	0.00M	0.27M	0.04M	-0.16M	0.02M	-0.03M	0.18M	-0.05M	0.03M	0.03M	-0.06M	-0.02M	0.03M	0.03M	0.10M	-0.08M
Other Working Capital Changes (Quarter)
Investing Activities
Capital Expenditures (Quarter)	2.19M	0.70M	-2.96M	0.07M	0.10M	0.29M	-0.43M	0.01M	0.20M	0.03M	-0.23M	0.08M	0.80M	-0.88M	0.06M	0.09M	0.05M	0.11M	-0.26M
Cash from Investing Activities (Quarter)	-1.71M	-0.70M	-0.48M	-0.16M	-0.08M	-59.74M	-3.91M	-0.01M	-0.21M	61.83M	-0.12M	-0.26M	-0.63M	-0.34M	-0.08M	-0.09M	-0.05M	-0.11M	-0.03M
Financing Activities
Other financing activities (Quarter)	3.98M	2.96M	0.03M							0.01M		0.06M	0.05M	0.06M	0.03M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)												10.00M				-10.00M			9.75M
Change in Capital Stock
Shares Issued (Quarter)	4.63M	4.67M	4.66M	4.64M	4.71M	4.67M	4.56M	5.17M	5.07M	5.06M	5.04M	4.43M	4.60M	4.51M	4.33M	5.30M	5.35M	5.23M	5.47M	5.38M
Net Equity Issued and Repurchased (Quarter)
Misc.
Cash from Financing Activities (Quarter)	3.98M	-72.04M	0.03M						-0.01M	0.01M		10.05M	0.05M	0.06M	0.28M	-10.25M
Exchange Rate Effect (Quarter)	0.32M	-0.24M	0.31M	0.12M	-0.56M	-4.33M	3.81M	-0.01M	0.13M	-1.54M	1.38M
Change in Cash (Quarter)	75.38M	-76.38M	-1.89M	-5.16M	-6.03M	-65.22M	-3.26M	-4.82M	-9.09M	58.80M	-2.17M	1.02M	-12.51M	-5.41M	-10.44M	-16.78M	-2.96M	-5.57M	-21.82M
Free Cash Flow (Quarter)	70.60M	-4.10M	1.20M	-5.19M	-5.49M	-1.44M	-2.73M	-4.82M	-9.20M	-1.52M	-3.21M	-7.28M	-12.18M	-4.97M	-6.60M	-6.81M	-6.04M	-4.37M	-22.70M
Net Cash Flow (Quarter)	75.06M	-76.14M	-2.20M	-5.28M	-5.47M	-60.89M	-7.07M	-4.81M	-9.22M	60.34M	-3.55M	2.60M	-11.96M	-6.12M	-6.34M	-17.06M	-6.04M	-4.37M	-22.99M

Research Tools

Datasets

Plans

Developers

XBiotech XBIT Cash Flow Statement (2014-2026)

Research Tools

Datasets

Plans

Developers

XBiotech XBIT Cash Flow Statement (2014-2026)

Create an account

Sign In

Reset Password